BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29977970)

  • 1. The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible
    Miller WR; Seas C; Carvajal LP; Diaz L; Echeverri AM; Ferro C; Rios R; Porras P; Luna C; Gotuzzo E; Munita JM; Nannini E; Carcamo C; Reyes J; Arias CA
    Open Forum Infect Dis; 2018 Jun; 5(6):ofy123. PubMed ID: 29977970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Characterization of the Cefazolin Inoculum Effect in North American Methicillin-Susceptible Staphylococcus aureus Isolates.
    Dingle TC; Gamage D; Gomez-Villegas S; Hanson BM; Reyes J; Abbott A; Burnham CD; Dien Bard J; Fritz S; Miller WR; Westblade LF; Zimmer B; Arias CA; Butler-Wu S;
    J Clin Microbiol; 2022 Jul; 60(7):e0249521. PubMed ID: 35578988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children.
    McNeil JC; Sommer LM; Boyle M; Hogan P; Vallejo JG; Hultén KG; Flores AR; Kaplan SL; Fritz S
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Test for the Rapid Detection of the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.
    Rincon S; Carvajal LP; Gomez-Villegas SI; Echeverri AM; Rios R; Dinh A; Pedroza C; Ordoñez KM; Nannini E; Sun Z; Fowler VG; Murray BE; Miller WR; Palzkill T; Diaz L; Arias CA; Reyes J
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33536292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Insights into the Classification of Staphylococcal β-Lactamases in Relation to the Cefazolin Inoculum Effect.
    Carvajal LP; Rincon S; Echeverri AM; Porras J; Rios R; Ordoñez KM; Seas C; Gomez-Villegas SI; Diaz L; Arias CA; Reyes J
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of cefazolin inoculum effect in serious MSSA infections: a systematic review.
    Lo CK; Sritharan A; Zhang J; Li N; Zhang C; Wang F; Loeb M; Bai AD
    JAC Antimicrob Resist; 2024 Jun; 6(3):dlae069. PubMed ID: 38716403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.
    Nannini EC; Stryjewski ME; Singh KV; Bourgogne A; Rude TH; Corey GR; Fowler VG; Murray BE
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3437-41. PubMed ID: 19487449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome.
    Chong YP; Park SJ; Kim ES; Bang KM; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):349-55. PubMed ID: 25213722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals.
    Rincón S; Reyes J; Carvajal LP; Rojas N; Cortés F; Panesso D; Guzmán M; Zurita J; Adachi JA; Murray BE; Nannini EC; Arias CA
    J Antimicrob Chemother; 2013 Dec; 68(12):2773-8. PubMed ID: 23794599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
    McDanel JS; Roghmann MC; Perencevich EN; Ohl ME; Goto M; Livorsi DJ; Jones M; Albertson JP; Nair R; O'Shea AMJ; Schweizer ML
    Clin Infect Dis; 2017 Jul; 65(1):100-106. PubMed ID: 28379314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of a Cefazolin Inoculum Effect Associated with
    Wang SK; Gilchrist A; Loukitcheva A; Plotkin BJ; Sigar IM; Gross AE; O'Donnell JN; Pettit N; Buros A; O'Driscoll T; Rhodes NJ; Bethel C; Segreti J; Charnot-Katsikas A; Singh K; Scheetz MH
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cefazolin Inoculum Effect and the Presence of type A
    Lee SO; Lee S; Park S; Lee JE; Lee SH
    Infect Chemother; 2019 Dec; 51(4):376-385. PubMed ID: 31898425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?
    Lee S; Choe PG; Song KH; Park SW; Kim HB; Kim NJ; Kim EC; Park WB; Oh MD
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5122-6. PubMed ID: 21825299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
    Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Cosgrove SE; Sakoulas G; Perencevich EN
    BMC Infect Dis; 2011 Oct; 11():279. PubMed ID: 22011388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.
    Monogue ML; Ortwine JK; Wei W; Eljaaly K; Bhavan KP
    J Infect Public Health; 2018; 11(5):727-731. PubMed ID: 29526442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort.
    Song KH; Jung SI; Lee S; Park S; Kiem SM; Lee SH; Kwak YG; Kim YK; Jang HC; Kim YS; Kim HI; Kim CJ; Park KH; Kim NJ; Oh MD; Kim HB;
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):285-294. PubMed ID: 27714592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and impact of methicillin-sensitive
    Svishchuk J; Ebbert K; Waddell B; Izydorczyk C; Acosta N; Somayaji R; Rabin HR; Bjornson CL; Lisboa L; Gregson DB; Conly JM; Surette MG; Parkins MD
    Antimicrob Agents Chemother; 2023 Dec; 67(12):e0013623. PubMed ID: 37966229
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
    Lee S; Song KH; Jung SI; Park WB; Lee SH; Kim YS; Kwak YG; Kim YK; Kiem SM; Kim HI; Kim ES; Park KH; Kim NJ; Jang HC; Kim HB;
    Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    Twilla JD; Algrim A; Adams EH; Samarin M; Cummings C; Finch CK
    Am J Med Sci; 2020 Jul; 360(1):35-41. PubMed ID: 32376001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.